536 related articles for article (PubMed ID: 31527085)
21. Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates cytokinesis.
Wang Z; Udeshi ND; Slawson C; Compton PD; Sakabe K; Cheung WD; Shabanowitz J; Hunt DF; Hart GW
Sci Signal; 2010 Jan; 3(104):ra2. PubMed ID: 20068230
[TBL] [Abstract][Full Text] [Related]
22. O-GlcNAc modification affects the ATM-mediated DNA damage response.
Miura Y; Sakurai Y; Endo T
Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
[TBL] [Abstract][Full Text] [Related]
23. Identification of the nuclear localisation signal of O-GlcNAc transferase and its nuclear import regulation.
Seo HG; Kim HB; Kang MJ; Ryum JH; Yi EC; Cho JW
Sci Rep; 2016 Oct; 6():34614. PubMed ID: 27713473
[TBL] [Abstract][Full Text] [Related]
24. Mutations in
Willems AP; Gundogdu M; Kempers MJE; Giltay JC; Pfundt R; Elferink M; Loza BF; Fuijkschot J; Ferenbach AT; van Gassen KLI; van Aalten DMF; Lefeber DJ
J Biol Chem; 2017 Jul; 292(30):12621-12631. PubMed ID: 28584052
[No Abstract] [Full Text] [Related]
25. Functional analysis of recombinant human and Yarrowia lipolytica O-GlcNAc transferases expressed in Saccharomyces cerevisiae.
Oh HJ; Moon HY; Cheon SA; Hahn Y; Kang HA
J Microbiol; 2016 Oct; 54(10):667-74. PubMed ID: 27687229
[TBL] [Abstract][Full Text] [Related]
26. O-GlcNAcylation regulates β1,4-GlcNAc-branched N-glycan biosynthesis via the OGT/SLC35A3/GnT-IV axis.
Song W; Isaji T; Nakano M; Liang C; Fukuda T; Gu J
FASEB J; 2022 Feb; 36(2):e22149. PubMed ID: 34981577
[TBL] [Abstract][Full Text] [Related]
27. Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB.
Phoomak C; Vaeteewoottacharn K; Sawanyawisuth K; Seubwai W; Wongkham C; Silsirivanit A; Wongkham S
Sci Rep; 2016 Jun; 6():27853. PubMed ID: 27290989
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial
Sacoman JL; Dagda RY; Burnham-Marusich AR; Dagda RK; Berninsone PM
J Biol Chem; 2017 Mar; 292(11):4499-4518. PubMed ID: 28100784
[No Abstract] [Full Text] [Related]
29. O-GlcNAc site-mapping of liver X receptor-α and O-GlcNAc transferase.
Fan Q; Moen A; Anonsen JH; Bindesbøll C; Sæther T; Carlson CR; Grønning-Wang LM
Biochem Biophys Res Commun; 2018 May; 499(2):354-360. PubMed ID: 29577901
[TBL] [Abstract][Full Text] [Related]
30. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
[TBL] [Abstract][Full Text] [Related]
31. The O-GlcNAc Modification of Recombinant Tau Protein and Characterization of the O-GlcNAc Pattern for Functional Study.
El Hajjar L; Bridot C; Nguyen M; Cantrelle FX; Landrieu I; Smet-Nocca C
Methods Mol Biol; 2024; 2754():237-269. PubMed ID: 38512671
[TBL] [Abstract][Full Text] [Related]
32. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
[TBL] [Abstract][Full Text] [Related]
33. Recognition of a glycosylation substrate by the O-GlcNAc transferase TPR repeats.
Rafie K; Raimi O; Ferenbach AT; Borodkin VS; Kapuria V; van Aalten DMF
Open Biol; 2017 Jun; 7(6):. PubMed ID: 28659383
[TBL] [Abstract][Full Text] [Related]
34. Genetic recoding to dissect the roles of site-specific protein O-GlcNAcylation.
Gorelik A; Bartual SG; Borodkin VS; Varghese J; Ferenbach AT; van Aalten DMF
Nat Struct Mol Biol; 2019 Nov; 26(11):1071-1077. PubMed ID: 31695185
[TBL] [Abstract][Full Text] [Related]
35. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
[No Abstract] [Full Text] [Related]
36. Aspartate Residues Far from the Active Site Drive O-GlcNAc Transferase Substrate Selection.
Joiner CM; Levine ZG; Aonbangkhen C; Woo CM; Walker S
J Am Chem Soc; 2019 Aug; 141(33):12974-12978. PubMed ID: 31373491
[TBL] [Abstract][Full Text] [Related]
37. Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation.
Smet-Nocca C; Broncel M; Wieruszeski JM; Tokarski C; Hanoulle X; Leroy A; Landrieu I; Rolando C; Lippens G; Hackenberger CP
Mol Biosyst; 2011 May; 7(5):1420-9. PubMed ID: 21327254
[TBL] [Abstract][Full Text] [Related]
38. Proteolysis of HCF-1 by Ser/Thr glycosylation-incompetent O-GlcNAc transferase:UDP-GlcNAc complexes.
Kapuria V; Röhrig UF; Bhuiyan T; Borodkin VS; van Aalten DM; Zoete V; Herr W
Genes Dev; 2016 Apr; 30(8):960-72. PubMed ID: 27056667
[TBL] [Abstract][Full Text] [Related]
39.
Zhao L; Li M; Wei T; Feng C; Wu T; Shah JA; Liu H; Wang F; Cai Y; Jin J
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31881804
[TBL] [Abstract][Full Text] [Related]
40. Cysteine S-linked N-acetylglucosamine (S-GlcNAcylation), A New Post-translational Modification in Mammals.
Maynard JC; Burlingame AL; Medzihradszky KF
Mol Cell Proteomics; 2016 Nov; 15(11):3405-3411. PubMed ID: 27558639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
